What is the difference between adjuvant and neoadjuvant treatment for Melanoma

Adjuvant vs. Neoadjuvant Treatment in Melanoma

Great question—these two terms describe when treatment happens relative to surgery, and the timing makes a real difference in your care plan.

Neoadjuvant Treatment: BEFORE Surgery

Neoadjuvant treatment is systemic therapy (medication that travels through your whole body) or other treatments given before your main surgery to remove the melanoma.

The goal: To shrink the tumor first, which can make surgery easier and more effective. According to the NCCN Guidelines for Patients: Melanoma, neoadjuvant therapy is used to reduce cancer before the main treatment.

When it's used:

• For melanoma that can't be easily removed by surgery (unresectable or borderline resectable disease)
• To potentially make a difficult surgical case more manageable
• In some cases of regional (stage 3) melanoma

Example: If you have a large melanoma in a difficult location, your doctor might give you immunotherapy or targeted therapy first to shrink it, then perform surgery once it's smaller.

---

Adjuvant Treatment: AFTER Surgery

Adjuvant treatment is therapy given after surgery to remove all visible cancer, when there's no evidence of disease remaining.

The goal: To reduce the risk that cancer will return by targeting any microscopic cancer cells that surgery might have missed.

When it's used:

• After successful surgery removes all visible melanoma
• For patients at higher risk of recurrence (based on stage and tumor characteristics)
• To improve long-term outcomes

Common adjuvant options for melanoma (according to NCCN Guidelines) include:

• Nivolumab (Opdivo) - an immunotherapy checkpoint inhibitor
• Pembrolizumab (Keytruda) - another checkpoint inhibitor
• Dabrafenib/trametinib - targeted therapy for patients with BRAF V600 mutations
• Observation - careful monitoring without additional treatment

---

Key Difference: The Timing

| Neoadjuvant | Adjuvant | |---|---| | Before surgery | After surgery | | Goal: Shrink tumor to make surgery possible/easier | Goal: Prevent recurrence after surgery | | Used when cancer is hard to remove | Used when cancer has been removed | | Systemic therapy or local treatments | Usually systemic therapy (drugs) |

---

Questions to Ask Your Oncologist

If your doctor recommends either approach, these questions can help you understand your specific situation:

1. "Why are you recommending neoadjuvant/adjuvant treatment for my melanoma?" (This helps you understand your risk factors)

2. "What specific drug or treatment are you recommending, and how does it work?"

3. "How long will treatment last, and what side effects should I expect?"

4. "How will we know if the treatment is working?" (For neoadjuvant: Is the tumor shrinking? For adjuvant: Are we preventing recurrence?)

5. "What happens if I choose not to have this treatment?" (Your doctor can explain the pros and cons for your specific case)

---

Important Context

According to the NCCN Guidelines for Patients: Melanoma, treatment decisions depend on your melanoma's stage, whether it can be surgically removed, and other tumor characteristics. Your oncologist will determine which approach—neoadjuvant, adjuvant, or both—makes the most sense for YOUR specific situation based on your complete medical picture.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.